Pain Relief for Acute Gouty Attack
For acute gout, initiate treatment within 24 hours with NSAIDs, corticosteroids, or colchicine as first-line options, with corticosteroids preferred in most patients due to superior safety profile and lower cost. 1, 2
First-Line Treatment Options
All three first-line agents have comparable efficacy for pain relief, but selection should be guided by patient comorbidities and contraindications:
NSAIDs
- Use full FDA-approved anti-inflammatory doses until the attack completely resolves 3
- FDA-approved options include:
- No single NSAID is superior to another; indomethacin has no efficacy advantage despite traditional preference 1, 2
- Pain relief typically begins within 2-4 hours, with tenderness and heat subsiding in 24-36 hours 4
- Avoid in patients with renal impairment, heart failure, peptic ulcer disease, or cardiovascular disease 2, 6
Corticosteroids (Preferred First-Line)
- Oral prednisone 0.5 mg/kg per day (or prednisolone 30-35 mg daily) for 5-10 days at full dose, then stop 3, 1
- Alternative: 2-5 days at full dose followed by 7-10 day taper 3, 1
- Safest option in patients with renal disease, elderly patients, or those with contraindications to NSAIDs/colchicine 1, 2
- For single joint involvement: intra-articular corticosteroid injection (dose varies by joint size) 3, 6
- For NPO patients with multiple joints: IV/IM methylprednisolone 0.5-2.0 mg/kg 6
- Lower risk of gastrointestinal bleeding, indigestion, nausea, and vomiting compared to NSAIDs 7
Colchicine
- Only effective if started within 36 hours of symptom onset 3
- Dosing: 1.2 mg loading dose, followed by 0.6 mg one hour later 3, 1
- Can continue with 0.6 mg once or twice daily 12 hours later until attack resolves 3
- Low-dose regimen is as effective as high-dose with significantly fewer gastrointestinal side effects 1, 6
- Requires dose adjustment in moderate to severe renal or hepatic impairment 3
- Avoid with strong P-glycoprotein or CYP3A4 inhibitors (cyclosporine, clarithromycin) 6
Treatment Algorithm Based on Severity
Mild to Moderate Pain (≤6/10) with Limited Joint Involvement (1-3 small joints or 1-2 large joints)
- Monotherapy with any first-line agent is appropriate 1, 2
- Choose based on patient comorbidities and contraindications
Severe Pain (≥7/10) or Polyarticular Involvement (≥4 joints)
Critical Management Principles
- Treatment must be initiated within 24 hours of symptom onset for optimal efficacy 3, 1
- Continue established urate-lowering therapy without interruption during acute attack 3, 1
- Do not initiate new urate-lowering therapy during an acute attack 2
- Educate patients on "pill in the pocket" approach to self-initiate treatment at first warning symptoms 2, 6
Adjunctive Measures
Management of Inadequate Response
- Inadequate response defined as <20% improvement in pain within 24 hours or <50% improvement after 24 hours 3
- Switch to another monotherapy or add a second recommended agent 6
- For severe refractory attacks: consider IL-1 inhibitors (canakinumab) off-label 3, 9
Common Pitfalls to Avoid
- Delaying treatment beyond 24 hours significantly reduces effectiveness 1, 6
- Do not use high-dose colchicine regimens - they increase toxicity without improving efficacy 1, 2, 6
- Do not preferentially use indomethacin - it has no efficacy advantage and potentially more adverse effects 2
- Do not discontinue urate-lowering therapy during acute flares 1, 6
- Screen for drug interactions with colchicine before prescribing 6